Rhode Island Chronicle

Yellow Fever Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Sanofi, GE Healthcare, BioCryst Pharma

 Breaking News
  • No posts were found

Yellow Fever Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies – Sanofi, GE Healthcare, BioCryst Pharma

September 13
00:22 2023
Yellow Fever  Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies - Sanofi, GE Healthcare, BioCryst Pharma
DelveInsight Business Research LLP
DelveInsight’s “Yellow Fever Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Yellow Fever, historical and forecasted epidemiology as well as the Yellow Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

DelveInsight’s “Yellow Fever Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Yellow Fever, historical and forecasted epidemiology as well as the Yellow Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Key Highlights 

  • Key Companies working on Yellow Fever include GE Healthcare, BioCryst Pharma, Sanofi and many others.

  • Key Therapies included in the Yellow Fever market include ISA-720 and many others.

Yellow Fever Overview

Yellow fever is an acute viral hemorrhagic disease transmitted by infected mosquitoes. The “yellow” in the name refers to the jaundice that affects some patients. Symptoms of yellow fever include fever, headache, jaundice, muscle pain, nausea, vomiting, and fatigue. 

Yellow fever is a viral disease of typically short duration.In most cases, symptoms include fever, chills, loss of appetite, nausea, muscle pains – particularly in the back – and headaches. Symptoms typically improve within five days.In about 15% of people, within a day of improving the fever comes back, abdominal pain occurs, and liver damage begins causing yellow skin. If this occurs, the risk of bleeding and kidney problems is increased.

The disease is caused by the yellow fever virus and is spread by the bite of an infected mosquito. It infects humans, other primates, and several types of mosquitoes. In cities, it is spread primarily by Aedes aegypti, a type of mosquito found throughout the tropics and subtropics. The virus is an RNA virus of the genus Flavivirus The disease may be difficult to tell apart from other illnesses, especially in the early stages. To confirm a suspected case, blood-sample testing with a polymerase chain reaction is required.

Yellow Fever  Epidemiology Insights

  • An estimated 90% of yellow fever infections occur on the African continent. In 2016, a large outbreak originated in Angola and spread to neighboring countries before being contained by a massive vaccination campaign. In March and April 2016, 11 imported cases of the Angola genotype in unvaccinated Chinese nationals were reported in China, the first appearance of the disease in Asia in recorded history.

Click here to learn more about the Yellow Fever Market Landscape

 

The Report Covers the Yellow Fever  Epidemiology Segmented by:

  • Yellow Fever  prevalent cases 

  • Yellow Fever  incident cases 

  • Yellow Fever  treatment cases 

  • Yellow Fever-diagnosed cases 

Yellow Fever Market Outlook 

The Yellow Fever market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Yellow Fever market trends by analyzing the impact of current Yellow Fever therapies on the market, Yellow Fever unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of the Yellow Fever market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Yellow Fever market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Yellow Fever market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Yellow Fever Market

  • GE Healthcare 

  • Sanofi 

  • BioCryst Pharmaceuticals 

And many others

Yellow Fever Therapies Covered and Analyzed in the Report

  •  ISA-720

  • SII-YFV

  •  Stamaril 

And many others 

Learn more about the Key Companies and Emerging Therapies in the Yellow Fever Market

Table of Contents 

  1.  Key Insights 

  2.  Yellow Fever  Introduction 

  3.  Executive Summary of Yellow Fever            

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  Yellow Fever  Emerging Therapies

  7.  Yellow Fever  Market Outlook

  8.  Market Access and Reimbursement of Therapies

  9.  Market Drivers 

  10.  Market Barriers 

  11.  Appendix

  12.  Report Methodology

  13.  DelveInsight Capabilities

  14.  Disclaimer

Learn about the detailed offerings of the report @ Yellow Fever Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Categories